1b Infections and Infestations of the Skin Flashcards

1
Q

What is panton valentine leukocidin?

A
  • It is a beta-pore forming toxin released by Staphylococcus aureus
  • Increased morbidity, mortality, trasmissability
  • Painful, multi-site, recurrent, present in contacts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the extracutaneous presentations of panton valentine leukocidin (3)?

A
  • Necrotising fasciitis
  • Necrotising pneumonia
  • Purpura fulminans
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the presentation?

A
  • Purpura fulminans
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the presentation?

A
  • Necrotising fasciitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

A patient presents with the following symptoms:

What is the most likely diagnosis?

A
  • Panton valentine leukocidin releasing staphylococcus aureus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the risks of acquiring panton valentine leukocidin releasing staphylococcus aureus (5Cs)?

A
  • Close contact
  • Contaminated items
  • Crowding
  • Cleanliness
  • Cuts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How is panton valentine leukocidin releasing staphylococcus aureus managed (4)?

A
  • Abx (often tetracycline)
  • Nasal ointment (mupirocin)
  • Chlorhexidine body wash
  • Treat contacts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the presentation?

A
  • Folliculitis (follicular erythema; sometimes pustular)

May be infectious or non-infectious (in HIV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

A patient presents with the following symptoms:

What is the most likely diagnosis?

A
  • May be infectious (Staphylococcus aureus, particularly strains expressing panton valentine leukocidin (PVL))

OR

  • Non-infectious (in HIV)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is folliculitis managed?

A
  • Antibiotics (usually flucloxacillin or erythromycin)
  • Incision and drainage is required for furunculosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the presentation?

What is the cause?

A
  • Pseudomonal folliculitis
  • Staphylococcus aureus from hot tub, swimming pool, depilatories, wet suits
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is a furuncle?

A
  • A furuncle is a deep follicular abscess involving one follicle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a carbuncle?

A
  • A carbuncle is a deep follicular abscess involving several adjacent follicles

More likely to lead to complications such as cellulitis and septicaemia than a furuncle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the presentation?

A
  • Cellulitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the cause of cellulitis (2)?

A
  • Streptococcus pyogenes
  • Staphylococcus aureus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is cellulitis managed (1)?

A
  • Systemic antibiotics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the presentation?

A
  • Impetigo
    • Superficial bacterial infection, stuck-on, honey-coloured crusts overlying an erosion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the cause of impetigo?

A
  • Streptococci (non-bullous)
  • Staphylococci (bullous)

Impetiginisation: occurs in atopic dermatitis-> superimposed infection -> gold crusting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How is impetigo managed (1)?

A
  • Topical +/- systemic antibiotics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the presentation?

A
  • Ecthyma
    • Severe form of streptococcal impetigo
    • Thick crust overlying a ‘punch out’ ulceration surrounded by erythema
    • Usually on lower extremities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

A patient presents with the following symptoms:

What is the diagnosis?

A
  • Staphylococcal Scalded Skin Syndrome (SSSS) due to exfoliative toxin

Neonates, infants or immunocompromised adults (In neonates, kidneys are immature so cannot excrete the exfoliative toxin quickly)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

A patient presents with the following symptoms:
* Fever > 38.9oC
* Hypotension
* Diffuse erythema
* Involvement of ≥ systems: GI, CNS, renal, hepatic, muscular
* Mucous membranes (erythema)
* Hematologic (platelets < 100 000/mm3)

What is the diagnosis?

A
  • Toxic shock syndrome due to Group A Staphylococcus aureus strain that produces pyrogenic exotoxin TSST-1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the presentation?

A
  • Necrotising fascitis
    • Initial dusky induration (usually of a limb), followed by rapid painful necrosis of skin, connective tissue and muscle.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the cause of necrotising fascitis?

A
  • Usually synergistic: streptococci, staphylococci, enterobacteriacee and anaerobes > Blood and tissue cultures can determine organisms and sensitivities.
25
Q

What is syphillis cased by?

A

Treponema pallidum

26
Q

What are the features of primary syphillis?

A
  • Primary infection Chancre - painless ulcer with a firm indurated border
  • Painless regional lymphadenopathy one week after the primary chancre
  • Chancre appears within 10-90 days
27
Q

A patient presents with the following symptoms:

What is the diagnosis?

A

Secondary syphillis
- begins 50 days after chancre

28
Q

What are the features of secondary syphillis?

A
  • Malaise, fever, headache, pruritus, loss of appetite, iritis
  • ‘Great mimicker’ - low threshold for testing- strong index of suspicion required
  • Rash (88-100%) -Pityriasis rosea-like rash
  • Alopecia (‘moth-eaten’)
  • Mucous patches
  • Lymphadenopathy
  • Residual primary chancre
  • Condylomata lata
  • Hepatosplenomegaly
29
Q

What is Lues maligna?

A
  • Rare manifestation of secondary syphilis
  • Pleomorphic skin lesions with pustules, nodules and ulcers with necrotising vasculitis
  • More frequent in HIV manifestation
30
Q

A patient presents with the following symptoms:

What is the diagnosis?

A

Tertiary syphillis

31
Q

What are the features of tertiary syphillis?

A
  • Gumma Skin lesions - nodules and plaques
    > Extend peripherally while central areas heal with scarring and atrophy
    > Mucosal lesions extend to and destroy the nasal cartilage
    > Cardiovascular disease
    > Neurosyphilis (general paresis or tabes dorsalis)
32
Q

What is the treatment of syphillis?

A

IM benzylpenicillin or oral tetracycline

33
Q

A patient presents with the following symptoms:

What is the diagnosis?

A
  • Lyme disease
    • Annular erythema from Borrelia infected tick bite

Borreliosis; 1-30 days from infection
* Neuroborreliosis
* Arthritis
* Carditis

34
Q

What are features of Lyme disease?

A
  • Initial cutaneous manifestation erythema migrans (papule at bite site then progression to annular erythema of more than 20cm)
  • 1-30 days after infection, fever, headache
  • Multiple secondary lesions develop - similar but smaller to initial lesion
  • Neuroborreliosis
  • Facial palsy / other CN palsies
  • Aseptic meningitis
  • Polyradiculitis
  • Arthritis - painful and swollen large joints (knee is the most affected join)
  • Carditis
35
Q

Treatment of Lyme disease?

A

-serology not sensitive and Histopathology non-specific (even though high index or suspicion required to diagnose, treat regardless as risk of progression is worse that risk of abx)

36
Q

What are the different presentations of herpes simplex virus (HSV) (4)?

A
  • Oral lesions: cold sores
  • Genital lesions
  • Herpetic whitlow
  • Eczema herpeticum
37
Q

How is herpes simplex virus (HSV) diagnosed?

A
  • Swab for polymerase chain reaction
38
Q

How is herpes simplex virus (HSV) managed (2)?

A
  • Oral valacyclovir or acyclovir 200mg five times daily in immunocompetent localised infection
  • Intravenous 10mg/kg TDS X 7-19 days if severe, systemic or at risk
39
Q

A patient presents with the following symptoms:

What is the diagnosis?

A
  • Oral lesion caused by herpes simplex virus (HSV-1)

HSV-1 is mainly transmitted by oral-to-oral contact to cause oral herpes (which can include symptoms known as “cold sores”), but can also cause genital herpes. HSV-2 is a sexually transmitted infection that causes genital herpes. Both HSV-1 and HSV-2 infections are lifelong.

40
Q

A patient presents with the following symptoms:

What is the diagnosis?

A
  • Genital lesion caused by herpes simplex virus (HSV-2)

HSV-1 is mainly transmitted by oral-to-oral contact to cause oral herpes (which can include symptoms known as “cold sores”), but can also cause genital herpes. HSV-2 is a sexually transmitted infection that causes genital herpes. Both HSV-1 and HSV-2 infections are lifelong.

41
Q

A patient presents with the following symptoms:

What is the diagnosis?

A
  • Eczema herpeticum
    • Monomorphic, punched out erosions (excoriated vesicles)

It’s an emergency!

42
Q

A patient presents with the following symptoms:

What is the diagnosis?

A
  • Herpetic whitlow
    • HSV (1>2) infection of digits - pain, swelling and vesicles (vesicles may appear later)

Misdiagnosed as paronychia or dactylitis
Often in children

43
Q

A patient presents with the following symptoms:

What is the diagnosis?

A
  • Candidiasis (Candida Albicans)
44
Q

A patient presents with the following symptoms:

What is the diagnosis and what is it caused by?

A
  • Scabies caused by sarcoptes species:
    • Female mates, burrows into epidermis, lays eggs and dies
45
Q

What are the features of Candidiasis (Candida Albicans)

A
  • warm moist areas (diabetes M)
  • Erythema odema- thin purulent discharge
  • Usually intertriginous infection (skin folds) or oral mucosa common cause of vulvovaginitis
  • Can become systemic (immunocompromise)
46
Q

What is the treatment for scabies?

A

permethrin, oral ivermectin
- Two cycles of treatment are required

47
Q

A patient presents with the following symptoms
*black crusty lesions
*redness and swelling
*Hx of diabetes mellitus

What is the diagnosis?

A

Mucormycosis

48
Q

What are the symptoms of mucormycosis?

A
  • Presentation: oedema, then pain, then eschar
  • fever, headache, proptosis, facial pain, orbital cellulitis ‡ cranial nerve dysfunction
49
Q

What is the treatment for mucormycosis?

A

Aggressive debridement & antifungal therapy amphoteracin

50
Q

What are the associations of mucormycosis?

A

Diabetes mellitus (1/3 of patients) - DKA very high risk
Malnutrition
Uraemia
Neutropaenia
Medications: Steroids / antibiotics / desferoxamine
Burns
HIV

51
Q

A patient presents with the following symptoms:

  • Hyper/hypopigmentation

What is the diagnosis?

A

Pityriasis versicolor

52
Q

Features of Pityriasis versicolor

A
  • Hypopigmented, hyperpigmented or erythematous macular eruption +/ - fine scale
  • Malassezia spp.
  • Begins during adolescence (when sebaceous glands become active)
  • Flares when temperatures and humidity are high - Immunosuppression
53
Q

Treatment of Pityriasis versicolor

A

Topical azole

54
Q

What are dermatophytes?

A

Fungi that live on keratin

55
Q

What is a Kerion?

A

An inflammatory fungal infection that may mimic a bacterial folliculitis or an abscess of the scalp; scalp is tender and patient usually has posterior cervical lymphadenopathy
- Frequently secondarily infected with Staphylococcus aureus

56
Q

What is tinea capitis and what is it caused by?

A

Scalp ringworm- caused by Trichophyton tonsurans

57
Q

What species causes the most fungal infections and give example of what it causes.

A

Trichophyton rubrum e.g. tinea pedis (athlete’s foot) and onychomycosis

58
Q

What is the Id reaction?

A
  • Aka Dermatophytid reactions
  • Inflammatory reactions at sites distant from the associated dermatophyte infection
  • May include urticaria, hand dermatitis, or erythema nodosum
  • Likely secondary to a strong host immunologic response against fungal antigens